发明名称 |
Quantitative analysis for diabetic condition predictor involving chiro-inositol |
摘要 |
An enhanced quantitative assay for chiro-inositol concentration can be used to determine insulin-resistance, or a predeposition to the development of insulin-resistance, in type I and type II diabetics. Spot urine or serum samples reflecting concentrations of chiro-inositol below about 1.0 micrograms/ml in urine or 0.1 micrograms/ml in serum are indicative of a predisposition to the development of insulin-resistance, while concentrations below about 0.3 micrograms/ml or 0.03 micrograms/ml in serum are associated with actual insulin-resistance symptoms. The assay can be employed for patient diagnosis, insulin therapy monitoring, and family screening.
|
申请公布号 |
US5183764(A) |
申请公布日期 |
1993.02.02 |
申请号 |
US19920870771 |
申请日期 |
1992.04.21 |
申请人 |
UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION |
发明人 |
KENNINGTON, ALISON S.;LARNER, JOSEPH |
分类号 |
C12Q1/26;G01N33/53;G01N33/66 |
主分类号 |
C12Q1/26 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|